TY - BOOK AU - Meneghetti, Fiorella||Barlocco, Daniela TI - Novel Antibacterial Agents SN - 9783040000000 KW - saccharin||tetrazole||1,3,4-thiadiazole||H7PX glioma cells||antimicrobial screening||antioxidant capacity||oxidative stress||natural products||medicinal plants||anti-infective agents||alternative infection models||antibacterial||anticancer||GC-MS||LIBS||Moringa oleifera||seed extract||MRSA||marine bisindole alkaloids||antibiofilm activity||adjuvants agents||VBNC cells||indole||thioxothiazolidine||antibacterial activity||antifungal activity||computer-aided prediction||docking||Mur B||CYP 51||plant compounds||diarrhea||selectivity||compounds screening||quorum sensing inhibition||molecular docking||AMP||antimicrobial activity||antiviral activity||bacteriocin||COVID-19||disinfectant||Lactobacillus plantarum||plantaricin||carbon nanotubes||quaternary ammonium groups||hyperbranched dendritic polymers||antibacterial properties||anti-cyanobacterial properties||3D-printing||dental polymer||antibacterial agent||coating||mesoporous silica nanoparticles||polydimethylsiloxane||Leishmania tropica and infantum||antileishmanial agents||lucanthone analogues||amitriptyline analogues||quinolizidine-derived compounds||molecular modelling studies||covalent inhibitor||MurA||cyclobutenaminone||irreversible||methicillin-resistant Staphylococcus aureus||essential oils||Origanum majorana||Rosmarinus officinalis||Thymus zygis||biofilm inhibition and eradication||urushiol||3-pentylcatechol||3-pentadecylcatechol||Helicobacter pylori||antimicrobial||triple therapy||atopic dermatitis||skin barrier||cutaneous dysbiosis||Staphylococcus aureus||microbial therapy||drug delivery systems||tris(1H-indol-3-yl)methylium||turbomycin||indole derivatives||antibacterial action||overcoming of drug resistance||biological activities||essential oil||extract||Thymus mastichina||imidazole and imidazolium salts||amino acid||antibacterial agents||aggregation||lipophilicity||antimicrobial peptide||biomembranes||ESKAPE||antibiotic resistance||NMR||molecular dynamics||biophysics||sequence alignment||lytic infection||antibiotic-resistance||Mycobacterium tuberculosis||Acinetobacter baumannii||Pseudomonas aeruginosa||phage production||magistral phage||pulmonary delivery||oral administration||topical delivery||Pinus cembra L.||Pinus mugo Turra||Picea abies L.||Abies alba M.||chemical investigation||HS-GC/MS||antioxidant activity||tuberculosis||mycobactins||furan||siderophores||drug design||bioisosterism||drug resistance||n/a UR - https://mdpi.com/books/pdfview/book/4830 ER -